About the study

  • This study was funded by a grant awarded by the National Institute of Health Research (NIHR) 
  •  The follow-up study is funded from three sources: a Cancer Research UK programme grant awarded to Professor       Martin who is working with us on some of the follow-up data, an award from the Research and Innovation Department   at University Hospitals Bristol, and Professor Ness' NIHR Senior Investigator Award.
  •  Researchers from Bristol University are leading the project and working with your local Head & Neck Team.

 

Background to Head and Neck 5000

  • There are around 9,000 new cases of head and neck cancer diagnosed each year in the UK.
  • The presence of additional illnesses unrelated to the tumour is high in people with head & neck cancer and can have a significant impact on their prognosis.
  • The two-year all-cause mortality, a measure of the number of deaths (in general, or due to a specific cause), is around 35% and this has not improved until recently.
  • Treatment for head & neck cancer is resource intensive because a person with head & neck cancer requires care from a range of disciplines.
  • The incidence and survival is affected by the individuals’ socio-economic status.
  • The centralisation of care to a smaller number of larger centres has implications for both people with head and neck cancer and their clinical team.